Skip to Main Content

Author Details

Mauro A A Castro
Federal University of Parana
1997
75
20
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37105962Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer.Nat Commun2023
37835376PD-1/PD-L1 Inhibitors Response in Triple-Negative Breast Cancer: Can Long Noncoding RNAs Be Associated?Cancers (Basel)2023
37084275spongEffects: ceRNA modules offer patient-specific insights into the miRNA regulatory landscape.Bioinformatics2023
37379765Sertraline as a potential cancer therapeutic approach: Biological relevance of TCTP in breast cancer cell lines and tumors.Adv Med Sci2023
34801336Corrigendum to "Identification of Differential Tumor Subtypes of T1 Bladder Cancer" [Eur. Urol. 78 (2020) 533-537].Eur Urol2022
36564410Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.Nat Commun2022
36358698Comprehensive Characterization of the Regulatory Landscape of Adrenocortical Carcinoma: Novel Transcription Factors and Targets Associated with Prognosis.Cancers (Basel)2022
36323682FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.Nat Commun2022
36192513A transcriptional network of cell cycle dysregulation in noninvasive papillary urothelial carcinoma.Sci Rep2022
34864914TreeAndLeaf: an R/Bioconductor package for graphs and trees with focus on the leaves.Bioinformatics2022
34136413Unraveling Immune-Related lncRNAs in Breast Cancer Molecular Subtypes.Front Oncol2021
33626341Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway.Cell Rep2021
33673003AKT3 Expression in Mesenchymal Colorectal Cancer Cells Drives Growth and Is Associated with Epithelial-Mesenchymal Transition.Cancers (Basel)2021
33670895Novel lncRNAs Co-Expression Networks Identifies LINC00504 with Oncogenic Role in Luminal A Breast Cancer Cells.Int J Mol Sci2021
35028613Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight.Cell Rep Med2021
34094909Dysregulation of Transcription Factor Networks Unveils Different Pathways in Human Papillomavirus 16-Positive Squamous Cell Carcinoma and Adenocarcinoma of the Uterine Cervix.Front Oncol2021
34194394Adrenocortical Carcinoma Steroid Profiles: <i>In Silico</i> Pan-Cancer Analysis of TCGA Data Uncovers Immunotherapy Targets for Potential Improved Outcomes.Front Endocrinol (Lausanne)2021
32848176Environmental prospecting of black yeast-like agents of human disease using culture-independent methodology.Sci Rep2020
31825805Which came first, the transcriptional regulator or its target genes? An evolutionary perspective into the construction of eukaryotic regulons.Biochim Biophys Acta Gene Regul Mech2020
32037144Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434-5.Eur Urol2020
31037648Cholinergic Differentiation of Human Neuroblastoma SH-SY5Y Cell Line and Its Potential Use as an In vitro Model for Alzheimer's Disease Studies.Mol Neurobiol2019
31427165Potential predictive value of cofilin-1 for metastasis occurrence in a small cohort of Argentinian patients with mid-low Breslow thickness melanoma.Pathol Res Pract2019
31250887RTNduals: an R/Bioconductor package for analysis of co-regulation and inference of dual regulons.Bioinformatics2019
30923832RTNsurvival: an R/Bioconductor package for regulatory network survival analysis.Bioinformatics2019
29180470ERα Binding by Transcription Factors NFIB and YBX1 Enables FGFR2 Signaling to Modulate Estrogen Responsiveness in Breast Cancer.Cancer Res2018
30218003DNA methylation in adolescents with anxiety disorder: a longitudinal study.Sci Rep2018
30096301Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.Cell2018
30361341The chromatin accessibility landscape of primary human cancers.Science2018
29755505Integrative Analysis Identifies Genetic Variants Associated With Autoimmune Diseases Affecting Putative MicroRNA Binding Sites.Front Genet2018
28986783Protein Function Prediction.Methods Mol Biol2017
28155214RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.Neurotox Res2017
28988769Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.Cell2017
26873489In vitro evaluation of antitumoral efficacy of catalase in combination with traditional chemotherapeutic drugs against human lung adenocarcinoma cells.Tumour Biol2016
26618344Regulators of genetic risk of breast cancer identified by integrative network analysis.Nat Genet2016
26262588miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma.Pancreas2016
27997592Identification of Post-Transcriptional Modulators of Breast Cancer Transcription Factor Activity Using MINDy.PLoS One2016
27207915Reduced Neurite Density in Neuronal Cell Cultures Exposed to Serum of Patients with Bipolar Disorder.Int J Neuropsychopharmacol2016
27236187FGFR2 risk SNPs confer breast cancer risk by augmenting oestrogen responsiveness.Carcinogenesis2016
27163206Differential expression of transcriptional regulatory units in the prefrontal cortex of patients with bipolar disorder: potential role of early growth response gene 3.Transl Psychiatry2016
27491988Draft Genome Sequence of Fonsecaea nubica Strain CBS 269.64, Causative Agent of Human Chromoblastomycosis.Genome Announc2016
25108670Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins.Mol Neurobiol2015
26302899Integrated Transcriptomics Establish Macrophage Polarization Signatures and have Potential Applications for Clinical Health and Disease.Sci Rep2015
25784483Potential crosstalk between cofilin-1 and EGFR pathways in cisplatin resistance of non-small-cell lung cancer.Oncotarget2015
25768658Correction: preferential duplication of intermodular hub genes: an evolutionary signature in eukaryotes genome networks.PLoS One2015
24018823High cofilin-1 levels correlate with cisplatin resistance in lung adenocarcinomas.Tumour Biol2014
24751578An analysis of the global expression of microRNAs in an experimental model of physiological left ventricular hypertrophy.PLoS One2014
24587745Differential evolutionary constraints in the evolution of chemoreceptors: a murine and human case study.ScientificWorldJournal2014
24449404Imbalance in redox status is associated with tumor aggressiveness and poor outcome in lung adenocarcinoma patients.J Cancer Res Clin Oncol2014
23468868Preferential duplication of intermodular hub genes: an evolutionary signature in eukaryotes genome networks.PLoS One2013
24349289Reverse engineering the neuroblastoma regulatory network uncovers MAX as one of the master regulators of tumor progression.PLoS One2013
  • 1 - 50 of 75

Recommended Authors

Harvard T. H. Chan School of Public Health
Career Start Year 2012
Number of shared co-authors 0
Baylor College of Medicine
Career Start Year 2008
Number of shared co-authors 0
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 21
Karolinska Institutet
Career Start Year 2006
Number of shared co-authors 1
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 2
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 3
Baylor College of Medicine
Career Start Year 2005
Number of shared co-authors 1
International Centre for Genetic Engineering and Biotechnology
Career Start Year 2004
Number of shared co-authors 0
Spanish National Cancer Research Centre (CNIO)
Career Start Year 2003
Number of shared co-authors 1
The University of Hong Kong
Career Start Year 2003
Number of shared co-authors 3
INSERM U, Institut Curie, PSL Research University
Career Start Year 2003
Number of shared co-authors 4
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 4
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 1
Virginia Commonwealth University
Career Start Year 2001
Number of shared co-authors 1
Institute of Statistical Science
Career Start Year 2001
Number of shared co-authors 1
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 13
Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center
Career Start Year 2000
Number of shared co-authors 7
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 2
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year 1999
Number of shared co-authors 18
Schroeder Arthritis Institute
Career Start Year 1998
Number of shared co-authors 4
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 20
University of Oslo
Career Start Year 1997
Number of shared co-authors 6
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 5
Berlin Institute of Health (BIH) and Charite
Career Start Year 1995
Number of shared co-authors 5
Columbia University
Career Start Year 1993
Number of shared co-authors 21
Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL)
Career Start Year 1989
Number of shared co-authors 1
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 5
University of California San Diego
Career Start Year 1988
Number of shared co-authors 11
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 1
University of Regensburg
Career Start Year 1969
Number of shared co-authors 1

Collaborators

Present address: Dxige Research Inc.
Co-authored papers 13
CNRS, Institut Curie, PSL Research University, Universite Paris Cite
Co-authored papers 9
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 5
Johns Hopkins School of Medicine
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Van Andel Institute
Co-authored papers 4
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 4
Broad Institute
Co-authored papers 3
Dana-Farber Cancer Institute
Co-authored papers 3
Co-authored papers 3
University of Texas MD Anderson Cancer Center
Co-authored papers 3
Co-authored papers 3
University of Alabama at Birmingham
Co-authored papers 2
University of Miami Miller School of Medicine
Co-authored papers 2
Co-authored papers 2
School of Pharmacy, University of Wisconsin-Madison
Co-authored papers 2
Nationwide Children's Hospital
Co-authored papers 2
Broad Institute
Co-authored papers 2
National Institute of Environmental Health Sciences (NIEHS)
Co-authored papers 2
University of British Columbia
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Cleveland Clinic.
Co-authored papers 2
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 2
National Cancer Institute
Co-authored papers 2
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 2
Fred Hutchinson Cancer Center
Co-authored papers 2
Co-authored papers 2
National Cancer Institute
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2